Innovative Cellular Therapeutics Holdings Ltd

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Innovative Cellular Therapeutics Holdings Ltd's trades of Lyell Immunopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-20 2026-07-17
S Sale
1,057 +10.7%
168.74
US$1,676,035 		1,057 +10.7% 168.74 US$1,676,035
2026-07-17 2026-07-16
S Sale
56,622 +32.2%
120.07
US$2,443,970 		56,622 +32.2% 120.07 US$2,443,970